Literature DB >> 15919222

Manipulating dendritic cells to induce regulatory T cells.

G Penna1, N Giarratana, S Amuchastegui, R Mariani, K C Daniel, L Adorini.   

Abstract

Dendritic cells (DCs) induce and regulate T-cell responses, and tolerogenic DCs can promote the development of regulatory T cells with suppressive activity. The possibility of manipulating DCs using different pharmacological or biological agents, enabling them to exert tolerogenic activities, could be exploited to better control a variety of chronic inflammatory conditions, from autoimmune diseases to allograft rejection.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15919222     DOI： 10.1016/j.micinf.2005.03.025

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  12 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.

Authors:  Jamal S Lewis; Natalia V Dolgova; Ying Zhang; Chang Qing Xia; Clive H Wasserfall; Mark A Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  Clin Immunol       Date:  2015-04-02       Impact factor: 3.969

Review 3.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

Review 4.  Epstein-Barr virus in multiple sclerosis.

Authors:  Bridget A Bagert
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

5.  Combinatorial delivery of immunosuppressive factors to dendritic cells using dual-sized microspheres.

Authors:  Jamal S Lewis; Chris Roche; Ying Zhang; Todd M Brusko; Clive H Wasserfall; Mark Atkinson; Michael J Clare-Salzler; Benjamin G Keselowsky
Journal:  J Mater Chem B       Date:  2014-05-07       Impact factor: 6.331

6.  Calcitriol analog ZK191784 ameliorates acute and chronic dextran sodium sulfate-induced colitis by modulation of intestinal dendritic cell numbers and phenotype.

Authors:  Ulrike G Strauch; Florian Obermeier; Nicole Grunwald; Nadja Dunger; Heiko C Rath; Jurgen Schölmerich; A Steinmeyer; U Zügel; H H Herfarth
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

7.  1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

Authors:  Louisa E Jeffery; Fiona Burke; Manuela Mura; Yong Zheng; Omar S Qureshi; Martin Hewison; Lucy S K Walker; David A Lammas; Karim Raza; David M Sansom
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

8.  Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells.

Authors:  A W Pedersen; K Holmstrøm; S S Jensen; D Fuchs; S Rasmussen; P Kvistborg; M H Claesson; M-B Zocca
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

9.  Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.

Authors:  Yanfei Huang; Matthew Parker; Changqing Xia; Ruihua Peng; Clive Wasserfall; Tracy Clarke; Lizhen Wu; Tayseer Chowdhry; Martha Campbell-Thompson; John Williams; Michael Clare-Salzler; Mark A Atkinson; Karl L Womer
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

Review 10.  Harnessing dendritic cells in inflammatory skin diseases.

Authors:  Chung-Ching Chu; Paola Di Meglio; Frank O Nestle
Journal:  Semin Immunol       Date:  2011-02-04       Impact factor: 11.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.